1. Home
  2. ABCL vs INMD Comparison

ABCL vs INMD Comparison

Compare ABCL & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABCL
  • INMD
  • Stock Information
  • Founded
  • ABCL 2012
  • INMD 2008
  • Country
  • ABCL Canada
  • INMD Israel
  • Employees
  • ABCL N/A
  • INMD N/A
  • Industry
  • ABCL Biotechnology: Pharmaceutical Preparations
  • INMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • ABCL Health Care
  • INMD Health Care
  • Exchange
  • ABCL Nasdaq
  • INMD Nasdaq
  • Market Cap
  • ABCL 772.9M
  • INMD 887.0M
  • IPO Year
  • ABCL 2020
  • INMD 2019
  • Fundamental
  • Price
  • ABCL $3.41
  • INMD $13.28
  • Analyst Decision
  • ABCL Strong Buy
  • INMD Hold
  • Analyst Count
  • ABCL 4
  • INMD 6
  • Target Price
  • ABCL $8.33
  • INMD $17.56
  • AVG Volume (30 Days)
  • ABCL 6.1M
  • INMD 1.1M
  • Earning Date
  • ABCL 08-05-2025
  • INMD 07-31-2025
  • Dividend Yield
  • ABCL N/A
  • INMD N/A
  • EPS Growth
  • ABCL N/A
  • INMD 8.69
  • EPS
  • ABCL N/A
  • INMD 2.29
  • Revenue
  • ABCL $23,114,000.00
  • INMD $392,408,000.00
  • Revenue This Year
  • ABCL N/A
  • INMD $0.16
  • Revenue Next Year
  • ABCL $66.89
  • INMD $4.84
  • P/E Ratio
  • ABCL N/A
  • INMD $5.79
  • Revenue Growth
  • ABCL N/A
  • INMD N/A
  • 52 Week Low
  • ABCL $1.89
  • INMD $13.16
  • 52 Week High
  • ABCL $3.68
  • INMD $19.85
  • Technical
  • Relative Strength Index (RSI)
  • ABCL 76.76
  • INMD 33.86
  • Support Level
  • ABCL $3.10
  • INMD $13.16
  • Resistance Level
  • ABCL $3.57
  • INMD $13.67
  • Average True Range (ATR)
  • ABCL 0.25
  • INMD 0.40
  • MACD
  • ABCL 0.10
  • INMD -0.09
  • Stochastic Oscillator
  • ABCL 89.68
  • INMD 7.23

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

About INMD InMode Ltd.

InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.

Share on Social Networks: